Paulo Nunes

Mr. Paulo Nunes


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2023 in Crystals
Verified
Journal Article
Open access
PDF file
PNPaulo Nunes
Paulo Nunes
PSPedro Henrique de Oliveira Santiago
Pedro Henrique de Oliveira Santiago
CSCecilia Carolina Pinheiro da Silva
Cecilia Carolina Pinheiro da Silva
Javier Alcides EllenaJavier Alcides Ellena
Javier Alcides Ellena
Drug repurposing is becoming interesting in terms of offering advantages over the traditional drug development, once drug discovery is a costly, time-consuming, and highly risky process. In particular, with the coronavirus disease (COVID-19) declared by World Health Organization as a global pandemic, there has emerged a considerable need to develop therapeutic agents capable of preventing viral outbreaks. Concomitantly, well-known and long-used drugs such as acyclovir (Acv) have been tested against COVID-19. Acv is a guanosine analogue that acts as an antiviral drug, commonly used to treat herpes simplex virus (HSV), genital herpes, and varicella zoster virus (VZV). Acv showed to inhibit viral proteases, multiple viral genes expression, and RNA-Dependent RNA Polymerase, helping to recover COVID-19 patients. However, ACV is a BCS class III/IV drug, with low permeability and/or slight water solubility (concentration-dependent). Given the repurposing eligibility of Acv, in this work, two new salts of this drug are presented (nitrate and sulfate), with the aim of improving its pharmacokinetic properties. The new salts were evaluated by X-ray diffraction, and thermal and spectroscopic analyses. A third salt, a chloride one, was also characterized and used for comparison.

21 December 2024 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PFPollyana Pereira Firmino
Pollyana Pereira Firmino
CSCecilia Carolina Pinheiro da Silva
Cecilia Carolina Pinheiro da Silva
PNPaulo Nunes
Paulo Nunes
JGJosé Eduardo Gonçalves
José Eduardo Gonçalves
FGFabrizia Grepioni
Fabrizia Grepioni
Javier Alcides EllenaJavier Alcides Ellena
Javier Alcides Ellena

31 January 2025 in EaD em Foco
Verified
Journal Article
Open access
PDF file
VDVictor Passarelli Destefane
Victor Passarelli Destefane
MMMiriam Garcia Manoel
Miriam Garcia Manoel
GGGabriel Ginja
Gabriel Ginja
GSGleyson Miranda de Souza
Gleyson Miranda de Souza
PNPaulo Nunes
Paulo Nunes
As diretrizes estabelecidas pela Lei nº 13.146 de 2015, conhecida como Estatuto da Pessoa com Deficiência, enfatiza a importância de criar ambientes inclusivos para o ensino de indivíduos com Transtorno do Espectro Autista (TEA). Através de uma análise documental feita pelos autores enquanto agentes em instituições paulistas de ensino superior pública presencial (Universidade de São Paulo) e a distância (Universidade Virtual do Estado de São Paulo), o presente artigo examina adaptações e identifica ferramentas e estratégias de aproveitamento e de processos de avaliação voltado para pessoas com TEA. O objetivo central é levantar abordagens pedagógicas adequadas, incorporando estratégias de ensino, tecnologias assistivas e outras intervenções que promovam o acesso, a participação ativa e a aprendizagem dentro deste universo. Em particular, nesta análise identificamos aspectos mais facilmente atendidos no ensino a distância comparativamente ao presencial. Palavras-chave: Transtorno do espectro autista. Ensino a distância. Adaptações.